Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 1, 2013, Pages

  Pettersson, Niclas ^a   Olsson, Caroline ^b   Tucker, Susan L ^c   Alsadius, David ^b   Wilderäng, Ulrica ^b   Johansson, Karl Axel ^a   Steineck, Gunnar ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; BRACHYTHERAPY; BT GROUPS; CONFIDENCE INTERVAL; EXTERNAL-BEAM RADIATION THERAPY; PROSTATE CANCERS;

DISEASES; RADIOTHERAPY;

HEALTH;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; TREATMENT OUTCOME; URETHRAL PAIN;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIATION DOSAGE; RADIOTHERAPY; SALVAGE THERAPY; SURVIVORS; TIME FACTORS; URETHRA; URETHRAL DISEASES; URINATION;

EID: 84871385180     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.08.037     Document Type: Article

References (18)

1. S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
2. D. Alsadius, M. Hedelin, and K.A. Johansson Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer Radiother Oncol 101 2011 495 501
3. H. Jin, S.L. Tucker, and H.H. Liu Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy Radiother Oncol 91 2009 427 432
4. G. Kovacs, R. Potter, and T. Loch GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer Radiother Oncol 74 2005 137 148 (Pubitemid 40331870)
5. P. Ghadjar, T. Keller, and C.A. Rentsch Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy Brachytherapy 8 2009 45 51
6. P. Ghadjar, O. Matzinger, and B. Isaak Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer Radiother Oncol 91 2009 237 242
7. L.B. Marks, P.R. Carroll, and T.C. Dugan The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy Int J Radiat Oncol Biol Phys 31 1995 1257 1280
8. G.M. Duchesne, S.G. Williams, and R. Das Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results Radiother Oncol 84 2007 128 134 (Pubitemid 47284528)
9. N. Mohammed, L. Kestin, and M. Ghilezan Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer Int J Radiat Oncol Biol Phys 82 2012 204 212
10. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC). Available at: http://ctep.cancer. gov/protocolDevelopment/electronic-applications/ctc.htm. Accessed June 1, 2012.
11. P. Rubin, L.S. Constine 3rd, and L.F. Fajardo EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system Radiother Oncol 35 1995 9 10
12. L. Budaus, M. Bolla, and A. Bossi Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature Eur Urol 61 2012 112 127
13. M.P. Schmid, R. Potter, and V. Bombosch Late gastrointestinal and urogenital side-effects after radiotherapy - incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer Radiother Oncol 104 2012 114 118
14. G. Steineck, K. Bergmark, and L. Henningsohn Symptom documentation in cancer survivors as a basis for therapy modifications Acta Oncol 41 2002 244 252 (Pubitemid 34833048)
15. U. Kreicbergs, U. Valdimarsdottir, and E. Onelov Talking about death with children who have severe malignant disease N Engl J Med 351 2004 1175 1186 (Pubitemid 39296305)
16. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694 (Pubitemid 19194494)
17. M. Astrahan Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation Med Phys 35 2008 4161 4172
18. G. Steineck, H. Hunt, and J. Adolfsson A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods Acta Oncol 45 2006 421 429 (Pubitemid 43884610)